Anthim OverviewObiltoxaximab (ETI-204, trade name Anthim) is a monoclonal antibody designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax). This drug was developed by Elusys Therapeutics, Inc. References ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Obiltoxaximab, American Medical Association. vteMonoclonal antibodies for infectious disease and toxinsFungal ("-fung-")Human ("-fungu-") Efungumab† Viral ("-v(i)[r]-")H...
Read more Anthim Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Obiltoxaximab
Recent Anthim Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 600mg/6ml
NDC Database Records for Anthim: (1 result)Sorted by National Drug Code
- 69604-204 Anthim 100 mg/ml Intravenous Solution by Elusys Therapeutics, Inc.